期刊文献+

微生态制剂预防婴幼儿抗菌药相关性腹泻的临床研究 被引量:8

Clinical Research of Microecologic Preparations in the Prevention of Antibiotic-associated Diarrhea in Infants
暂未订购
导出
摘要 目的:探讨微生态制剂对婴幼儿抗菌药相关性腹泻(AAD)的预防作用。方法:360例因肺炎住院的婴幼儿随机分为2组,治疗组172例,在使用抗菌药的同时口服微生态制剂(酪酸梭菌糖化菌肠球菌活菌制剂),100 mg,tid;对照组188例,仅使用抗菌药,不使用微生态制剂。两组患儿均给予相同的对症治疗,比较两组AAD发生率及腹泻病程。结果:治疗组有15例(8.72%)患儿发生AAD,对照组有49例(26.06%)发生AAD,两组发生率差异有统计学意义(P<0.05);治疗组AAD患儿腹泻持续时间(3.62±1.53)d,明显低于对照组持续时间(6.45±1.98)d(P<0.05)。结论:微生态制剂能有效预防婴幼儿AAD。 Objective:To investigate the preventive effect of microecologic preparations on antibiotic-associated diarrhea in infants. Method:Three hundred and sixty hospitalized inlants with pneumonia were randomly divided into two groups,the therapy group and the control group.The treatment protocol for 172 cases in the therapy group was oral 300mg/d microecologic preparations and antibiotics, while that for 188 cases in the control group was antibiotics alone.The same symptomatic treatment was applied in the two groups.The incidence of antibiotic-associated diarrhea and the diarrhea duration were compared between the two groups.Result:The incidence of antibiotic-associated diarrheain in the therapy group(8.72%) was significantly lower than that in the control group (26.06%,P 0.05).The diarrhea duration in the therapy group[(3.62±1.53)d]was significantly shorter than that in the control group([(6.45±1.98)d,P0.05).Conclusion:Microecologic preparations can effectively prevent antibiotic-associated diarrhea in infants.
作者 高源 姜赤秋
出处 《中国药师》 CAS 2013年第3期420-421,共2页 China Pharmacist
关键词 微生态制剂 抗菌药相关性腹泻 婴幼儿 预防 Microecologic preparations Antibiotic-associated diarrhea Infant Prevention
  • 相关文献

参考文献9

二级参考文献42

共引文献145

同被引文献70

  • 1乔俊英,王秀芳,栾斌.婴幼儿重症肺炎181例临床分析[J].郑州大学学报(医学版),2009,44(6):1293-1294. 被引量:11
  • 2王廷丽.丙氨酰-谷氨酰胺治疗烧伤后抗生素相关性腹泻的疗效分析[J].黑龙江医学,2013,37(1):27-29. 被引量:3
  • 3方颖,董玲,沈锡中.抗生素相关性腹泻[J].世界临床药物,2006,27(12):724-728. 被引量:39
  • 4Pozzoni P, Riva A, Bellatorre AG, et al. Saceharomyces boulardii for the preven- tion of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, ran- domized, double-blind, placebo-control- led trial[J]. Am J Gastroenterol,2012,107 (6):922-931.
  • 5Varughese CA, Vakil NH, Phillips KM. Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics-continuing education article[J].J Pharm Pract,2013,26(5):476-482.
  • 6Colman RJ,Rubin DT.Fecal microbiota transplantation as therapy for inflammatory bowel disease:a systematic review and metaanalysis[J].J Crohns Colitis,2014,8(12):1569-1581.
  • 7Youngster I,Sauk J,Pindar C,et al.Fecal microbiota transplant for relapsing clostfdium diffieile infection using a frozen inoculum from unrelated donors:a randomized,open-label,controlled pilot study[J].Clin Infect Dis,2014,58(11):1515-1522.
  • 8Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent clostridium dimcile infection[J].Am J Gastroenterol,2012,107(7):1079-1087.
  • 9van Nood E,Vrieze A,Nieuwdorp M,et al.Duodenal infusion of donor feces for recurrent clostridium diffieile[J].N Engl J Med,2013,368(5):407-415.
  • 10Feizizadeh S,Salehi-Abargouei A,Akbari V.Efficacy and safety of Saccharomyees boulardii for acute diarrhea[J].Pediatrics,2014,134(1):e176-e191.

引证文献8

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部